PharmTech Drug Digest 11.20
News|Articles|February 4, 2014

Puerto Rico Opens Research and Development Center for Pharmaceutical Products

Author(s)Melanie Sena

Neolpharma opens its new Development and Innovation Center (CEDIPROF) for pharmaceutical products in Puerto Rico.

The Puerto Rico Industrial Development Company and governor Alejandro García Padilla had an inauguration ceremony for Neolpharma's new Development and Innovation Center (CEDIPROF) for pharmaceutical products in Puerto Rico.

In 2013, Neolpharma invested over $12 million in machinery and equipment in the center in Puerto Rico. The center will create 23 new jobs. CEDIPROF includes a 2000 ft2 pilot facility for research, development, and evaluation of new pharmaceutical products, as well as an analytic and forensic laboratory and a 4000 ft2 warehouse.

Source: Puerto Rico Industrial Development Company


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.